SCHEMBL1333067

SCHEMBL1333067

C=C(C)COCc1ccc(/C=C/C(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.49
PKM P14618 2/20 0.49
CA12 O43570 2/20 0.49
AKR1B10 O60218 2/20 0.49
AKR1B1 P15121 2/20 0.49
CA4 P22748 2/20 0.49
CA6 P23280 2/20 0.49
CA5A P35218 2/20 0.49
CA7 P43166 2/20 0.49
CA9 Q16790 2/20 0.49
CA14 Q9ULX7 2/20 0.49
CA5B Q9Y2D0 2/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
ESR1 P03372 1/20 0.49
CA3 P07451 1/20 0.49
TYR P14679 1/20 0.49
DPP4 P27487 1/20 0.49
ESR2 Q92731 1/20 0.49
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1333069 0.79 CA12 (0.49) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL3696843 0.79 THRB (0.58) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL3696841 0.79 THRB (0.58) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL7135819 0.78 THRB (0.61) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL7135813 0.78 THRB (0.61) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL3316810 0.76 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL13357890 0.76 HCAR2 (0.60) HCAR2PKMCA12AKR1B10AKR1B1
Methacrylic Acid SCHEMBL10714814 0.74 HCAR2 (0.49) HCAR2PKMCA12AKR1B10AKR1B1
SCHEMBL793986 0.73 TSHR (0.56) CA7CA9CA1CA2KDM4E
SCHEMBL15237047 0.73 HCAR2 (0.56) HCAR2PKMCA12AKR1B10AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753686-B2 Surface-treating agents, surface-treated powders, and cosmetics comprising the same SHISEIDO CO., LTD. (JP) 2014-06-17 US disclosed
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same SHISEIDO CO., LTD. (JP) 2011-11-17 US disclosed
EP-2112179-B1 Surface-treated powders, and cosmetics comprising the same SHISEIDO CO LTD (JP) 2011-04-27 EP disclosed
EP-1803750-B1 USE OF A POLYMER FOR SURFACE-TREATING A POWDER SHISEIDO CO LTD (JP) 2009-12-09 EP disclosed
EP-2112179-A1 Surface-treated powders, and cosmetics comprising the same Shiseido Co., Ltd. (JP) 2009-10-28 EP disclosed
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability SHISEIDO CO., LTD. (JP) 2008-04-03 US disclosed
EP-1803750-A1 SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME Shiseido Company, Limited (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability CHRM1, H1-0, H1-2 HCAR2 615/4885PKM 1289/4885CA12 2086/4885
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same CHRM1, H1-0, H1-2 HCAR2 1527/4885PKM 1366/4885CA12 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.